Endocrine Neoplasia and Cancer

Our members are leading the study of the molecular roots of cancer and endocrine neoplasias, as well as the effectiveness of various therapies, to identify new and better ways to treat these diseases. Hormone-related cancers—including breast, prostate, and thyroid cancer—rank among the most common forms of the condition. In addition to tackling these conditions, our members’ research also offers hope for individuals diagnosed with rare conditions, such as adrenal cancer and multiple endocrine neoplasia.

Meetings

Hormonal Influences on Immunity and Cancer: On-Demand Streaming Now Available

Now you can access the education from our October 5–8 conference with Keystone Symposia that was held in Breckenridge, CO, US. Explore emerging research on sex differences in cancer outcomes, immunotherapy, neuroendocrine signaling, aging, puberty, pregnancy, menopause, AI-enabled discovery, and the tumor microenvironment. Watch the sessions.

Now you can access the education from our October 5–8 conference with Keystone Symposia that was held in Breckenridge, CO, US. Explore emerging research on sex differences in cancer outcomes, immunotherapy, neuroendocrine signaling, aging, puberty, pregnancy, menopause, AI-enabled discovery, and the tumor microenvironment. Watch the sessions.

Membership

Become a Member

Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.

Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.